More news
- Axalta releases Q1 2024 results
- PPG again earns EcoVadis gold rating for sustainability practices, ranking among top 7% of...
- Baikowski® France 2030 plan winner for its innovative project to decarbonise alumina prod...
- New CEO at BASF: Martin Brudermüller hands over to Markus Kamieth
- Wacker stays below prior-year figures amid lower selling prices in Q1
AkzoNobel and Evonik have joined forces to build and operate a new membrane electrolysis facility for potassium hydroxide solution and chlorine in Germany. Start-up is expected by the end of 2017.
The 50-50 JV involves the construction and operation of a dedicated plant at AkzoNobel’s existing site in Ibbenbüren. It will have a nameplate capacity of around 130,000t/yr of potassium hydroxide solution and 82,000t of chlorine. This will strengthen the leading market positions of both companies. Financial details were not disclosed.
AkzoNobel will take over commercialisation of chlorine and hydrogen at the new plant and will process these products directly at the Ibbenbüren site. Evonik will take over the potassium hydroxide solution for commercialisation and processing at its own site in Lülsdorf. This is where Evonik processes potassium hydroxide solution into potassium carbonate (potash).